Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HYLN | BCAL |
|---|---|---|
| Price | $3.85 | $21.38 |
| Change today | ▼ 4.70% | ▼ 1.29% |
| Market cap | $687.60M | $687.38M |
| Return, 3 months | -9.4% | +5.0% |
| Return, year to date | +109.2% | +16.4% |
| Return, 1 year | +53.4% | +30.9% |
| P/E (TTM) | -13.3 | 11.6 |
| P/B | 4.1 | 1.2 |
| P/E percentile vs own 5y | 7th | 60th |
| Dividend yield | – | 1.40% |
| Revenue growth (YoY, latest qtr) | +226.3% | +1.4% |
| Net profit growth (YoY) | -3.8% | +1.4% |
| Gross margin | 6.5% | – |
| Operating margin | -648.7% | – |
| Net margin | -564.3% | 33.4% |
| Return on equity | -27.1% | 10.6% |
| Analyst target vs. price | +125.2% | +14.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 46 | 46 |
| 30-day volatility | 64.1% | 14.3% |
| Max drawdown, 1 year | -61.1% | -13.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
